Percutaneous mitral annular reduction provides continued benefit in an ovine model of dilated cardiomyopathy

Circulation

Volumn 110, Issue 19, 2004, Pages 3088-3092

  Byrne, Melissa J ^a   Kaye, David M ^a   Mathis, Mark ^b   Reuter, David G ^b   Alferness, Clif A ^b   Power, John M ^a  

^a BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

^b Cardiac Dimensions Inc   (United States)

Author keywords

Cardiology; Cardiomyopathy; Catheterization; Mitral valve; Regurgitation

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; NEUROHORMONE; NORADRENALIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANNULOPLASTY; ARTICLE; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; DEVICE; ECHOCARDIOGRAPHY; HEART HEMODYNAMICS; HEART LEFT VENTRICLE DP-DT; HEART RIGHT VENTRICLE; HEART VALVE REPLACEMENT; HEART VENTRICLE PACING; HORMONE DETERMINATION; LUNG CAPILLARY PRESSURE; MITRAL VALVE REGURGITATION; NONHUMAN; NORADRENALIN BLOOD LEVEL; PRIORITY JOURNAL; SHEEP;

ANIMALS; CARDIAC PACING, ARTIFICIAL; CARDIOMYOPATHY, DILATED; FOLLOW-UP STUDIES; HEMODYNAMIC PROCESSES; MITRAL VALVE; MITRAL VALVE INSUFFICIENCY; NATRIURETIC PEPTIDE, BRAIN; NOREPINEPHRINE; PROSTHESES AND IMPLANTS; PULMONARY WEDGE PRESSURE; RANDOM ALLOCATION; SHEEP;

EID: 8544280730     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.0000146904.13677.E4     Document Type: Article

References (32)

1. Blondheim DS, Jacobs LE, Kotler MN, Costacurta GA, Parry WR. Dilated cardiomyopathy with mitral regurgitation: decreased survival despite a low frequency of left ventricular thrombus. Am Heart J. 1991;122:763-771.
2. Robbins JD, Maniar PB, Cotts W, Parker MA, Borrow RO, Gheorghiade M. Prevalence and severity of mitral regurgitation in chronic systolic heart failure. Am J Cardiol. 2003;91:360-362.
3. Junker A, Thayssen P, Nielsen B, Andersen PE. The hemodynamic and prognostic significance of echo-Doppler-proven mitral regurgitation in patients with dilated cardiomyopathy. Cardiology. 1993;83:14-20.
4. Nagatsu M, Zile MR, Tsutsui H, Schmid PG, DeFreyte G, Cooper GT, Carabello BA. Native beta-adrenergic support for left ventricular dysfunction in experimental mitral regurgitation normalizes indexes of pump and contractile function. Circulation. 1994;89:818-826.
5. Mehta RH, Supiano MA, Oral H, Grossman PM, Petrusha JA, Montgomery DG, Briesmiester KA, Smith MJ, Starling MR. Relation of systemic sympathetic nervous system activation to echocardiographic left ventricular size and performance and its implications in patients with mitral regurgitation. Am J Cardiol. 2000;86:1193-1197.
6. Oral H, Sivasubramanian N, Dyke DB, Mehta RH, Grossman PM, Briesmiester K, Fay WP, Pagani FD, Boiling SF, Mann DL, Starling MR. Myocardial proinflammatory cytokine expression and left ventricular remodeling in patients with chronic mitral regurgitation. Circulation. 2003;107:831-837.
7. Masson S, Gorini M, Salio M, Lucci D, Latini R, Maggioni AP, for the IN-CHF Investigators. Clinical correlates of elevated plasma natriuretic peptides and big endothelin-1 in a population of ambulatory patients with heart failure: a substudy of the Italian Network on Congestive Heart Failure (IN-CHF) registry. Ital Heart J. 2000;1:282-288.
8. Kaye DM, Jennings GL, Dart AM, Esler MD. Differential effect of acute baroreceptor unloading on cardiac and systemic sympathetic tone in congestive heart failure. J Am Coll Cardiol. 1998;31:583-587.
9. Otsuji Y, Handschumacher MD, Schwammenthal E, Jiang L, Song JK, Guerrero JL, Vlahakes GJ, Levine RA. Insights from three-dimensional echocardiography into the mechanism of functional mitral regurgitation: direct in vivo demonstration of altered leaflet tethering geometry. Circulation. 1997;96:1999-2008.
10. Timek TA, Dagum P, Lai DT, Liang D, Daughters GT, Ingels NB Jr, Miller DC. Pathogenesis of mitral regurgitation in tachycardia-induced cardiomyopathy. Circulation. 2001;104:1-47-1-53.
11. Kono T, Sabbah HN, Rosman H, Alam M, Jafri S, Goldstein S. Left ventricular shape is the primary determinant of functional mitral regurgitation in heart failure. J Am Coll Cardiol. 1992;20:1594-1598.
12. Nemoto S, Hamawaki M, De Freitas G, Carabello BA. Differential effects of the angiotensin-converting enzyme inhibitor lisinopril versus the beta-adrenergic receptor blocker atenolol on hemodynamics and left ventricular contractile function in experimental mitral regurgitation. J Am Coll Cardiol. 2002;40:149-154.
13. Varriale P, David W, Chryssos BE. Hemodynamic response to intravenous enalaprilat in patients with severe congestive heart failure and mitral regurgitation. Clin Cardiol. 1993;16:235-238.
14. Byrne MJ, Raman JS, Alferness CA, Esler MD, Kaye DM, Power JM. An ovine model of tachycardia-induced degenerative dilated cardiomyopathy and heart failure with prolonged onset. J Card Fail. 2002;8:108-115.
15. Kaye DM, Byrne M, Alferness C, Power J. Feasibility and short-term efficacy of percutaneous mitral annular reduction for the therapy of heart failure-induced mitral regurgitation. Circulation. 2003;108:1795-1797.
16. Eisenhofer G, Goldstein DS, Stull R, Keiser HR, Sunderland T, Murphy DL, Kopin IJ. Simultaneous liquid-chromatographic determination of 3,4-dihydroxyphenylglycol, catecholamines, and 3,4-dihydroxyphenylalanine in plasma, and their responses to inhibition of monoamine oxidase. Clin Chem. 1986;32:2030-2033.
17. Medvedev OS, Esler MD, Angus JA, Cox HS, Eisenhofer G. Simultaneous determination of plasma noradrenaline and adrenaline kinetics: responses to nitroprusside-induced hypotension and 2-deoxyglucose-induced glucopenia in the rabbit. Naunyn Schmiedebergs Arch Pharmacol. 1990;341:192-199.
18. Pemberton CJ, Yandle TG, Charles CJ, Rademaker MT, Aitken GD, Espiner EA. Ovine brain natriuretic peptide in cardiac tissues and plasma: effects of cardiac hypertrophy and heart failure on tissue concentration and molecular forms. J Endocrinol. 1997;155:541-550.
19. Rademaker MT, Cameron VA, Charles CJ, Espiner EA, Nicholls MG, Pemberton CJ, Richards AM. Neurohormones in an ovine model of compensated postinfarction left ventricular dysfunction. Am J Physiol. 2000;278:H731-H740.
20. Lamas GA, Mitchell GF, Flaker GC, Smith SC Jr, Gersh BJ, Basta L, Moye L, Braunwald E, Pfeffer MA, for the Survival and Ventricular Enlargement Investigators. Clinical significance of mitral regurgitation after acute myocardial infarction. Circulation. 1997;96:827-833.
21. Otto CM. Timing of surgery in mitral regurgitation. Heart. 2003;89:100-105.
22. Urschel CW, Covell JW, Sonnenblick EH, Ross J Jr, Braunwald E. Myocardial mechanics in aortic and mitral valvular regurgitation: the concept of instantaneous impedance as a determinant of the performance of the intact heart. J Clin Invest. 1968;47:867-883.
23. Wisenbaugh T, Spann JF, Carabello BA. Differences in myocardial performance and load between patients with similar amounts of chronic aortic versus chronic mitral regurgitation. J Am Coll Cardial. 1984;3:916-923.
24. Wong CY, Spotnitz HM. Systolic and diastolic properties of the human left ventricle during valve replacement for chronic mitral regurgitation. Am J Cardiol. 1981;47:40-50.
25. Schuler G, Peterson KL, Johnson A, Francis G, Dennish G, Utley J, Daily PO, Ashburn W, Ross J Jr. Temporal response of left ventricular performance to mitral valve surgery. Circulation. 1979;59:1218-1231.
26. Nakano K, Swindle MM, Spinale F, Ishihara K, Kanazawa S, Smith A, Biederman RW, Clamp L, Hamada Y, Zile MR, et al. Depressed contractile function due to canine mitral regurgitation improves after correction of the volume overload. J Clin Invest. 1991;87:2077-2086.
27. Tsutsui H, Spinale FG, Nagatsu M, Schmid PG, Ishihara K, DeFreyte G, Cooper Gt, Carabello BA. Effects of chronic beta-adrenergic blockade on the left ventricular and cardiocyte abnormalities of chronic canine mitral regurgitation. J Clin Invest. 1994;93:2639-2648.
28. Kaye DM, Lefkovits J, Jennings GL, Bergin P, Broughton A, Esler MD. Adverse consequences of high sympathetic nervous activity in the failing human heart. J Am Coll Cardiol. 1995;26:1257-1263.
29. Mukoyama M, Nakao K, Hosoda K, Suga S, Saito Y, Ogawa Y, Shirakami G, Jougasaki M, Obata K, Yasue H, et al. Brain natriuretic peptide as a novel cardiac hormone in humans: evidence for an exquisite dual natriuretic peptide system, atrial natriuretic peptide and brain natriuretic peptide. J Clin Invest. 1991;87:1402-1412.
30. Maisel AS, Krishnaswamy P, Nowak RM, McCord J, Hollander JE. Duc P, Omland T, Storrow AB, Abraham WT, Wu AH, Clopton P, Steg PG, Westheim A, Knudsen CW, Perez A, Kazanegra R, Herrmann HC, McCullough PA. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med. 2002;347:161-167.
31. Tsang TS, Barnes ME, Gersh BJ, Bailey KR, Seward JB. Left atrial volume as a morphophysiologic expression of left ventricular diastolic dysfunction and relation to cardiovascular risk burden. Am J Cardiol. 2002;90:1284-1289.
32. Hueb AC, Jatene FB, Moreira LF, Pomerantzeff PM, Kallas E, de Oliveira SA. Ventricular remodeling and mitral valve modifications in dilated cardiomyopathy: new insights from anatomic study. J Thorac Cardiovasc Surg. 2002;124:1216-1224.